Give Hope Blog
City of Hope researcher moves in on leukemia's ‘neighborhood’
July 11, 2019 | Abe Rosenberg
Inspiration came early to Nadia Carlesso, M.D., Ph.D., associate director of basic research in the Gehr Family Center for Leukemia Research at City of Hope.
ASCO research highlights: First KRAS inhibitor and CAR T cell therapy for CLL
June 28, 2019 | City of Hope
At ASCO, City of Hope presented on a number of topics, but some of the most noteworthy involved the first KRAS inhibitor to show anti-tumor activity and the use of CAR T cell therapy in chronic lymphocytic leukemia.
Survivor Month: A second chance, thanks to CAR T trial
June 27, 2019 | Dory Benford
Tyler Routh is one of 13 leukemia patients who had a remarkable recovery after participating in Dr. Samer Khaled’s CAR T trial.
Bone Marrow Donor Travels Across Country to Meet 8-Year-Old Recipient
May 10, 2019 | Letisia Marquez
Father of two Rosendo Moreno of Chicago didn't hesitate when Be The Match asked if he would be interested in being a bone marrow donor for 5-year-old Zuleika Flores of San Diego. Three years later, they finally meet.
Leukemia patient finds donor halfway around the world
May 9, 2019 | Letisia Marquez
Acute myeloid leukemia patient Leif Voeltz's perfect match for a bone marrow transplant was located in Germany. Now Marcel Waldmann is traveling to the U.S. for the first time to meet the man whose life he saved.
Bone marrow transplants have broken the age barrier
May 7, 2019 | Abe Rosenberg
City of Hope’s bone marrow transplant program recently performed the procedure on its 15,000th patient. Today, age is no longer a barrier to transplant.
Half-matches open door to bone marrow transplant for more patients
May 6, 2019 | Abe Rosenberg
City of Hope doctors have performed more than 250 haploidentical stem cell transplants in the last five years. They are giving more and more patients a new treatment option.
City of Hope investigates a novel therapeutic approach in AML
April 26, 2019 | City of Hope
City of Hope opens recruitment for a phase I/II dose-finding study of novel agent 8-chloro-adenosine in patients with relapsed/refractory acute myeloid leukemia.
Load MoreBack To Top